- Home
- BBD vs BNTX Comparison
BBD vs BNTX Comparison
Compare BBD & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBD
- BNTX
- Stock Information
- Founded
- BBD 1943
- BNTX 2008
- Country
- BBD Brazil
- BNTX Germany
- Employees
- BBD N/A
- BNTX N/A
- Industry
- BBD Major Banks
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BBD Finance
- BNTX Health Care
- Exchange
- BBD Nasdaq
- BNTX Nasdaq
- Market Cap
- BBD 30.6B
- BNTX 26.4B
- IPO Year
- BBD N/A
- BNTX 2019
- Fundamental
- Price
- BBD $3.20
- BNTX $99.43
- Analyst Decision
- BBD Strong Buy
- BNTX Strong Buy
- Analyst Count
- BBD 4
- BNTX 18
- Target Price
- BBD $2.55
- BNTX $139.49
- AVG Volume (30 Days)
- BBD 34.2M
- BNTX 1.2M
- Earning Date
- BBD 10-30-2025
- BNTX 11-03-2025
- Dividend Yield
- BBD 4.87%
- BNTX N/A
- EPS Growth
- BBD 58.81
- BNTX N/A
- EPS
- BBD 0.36
- BNTX N/A
- Revenue
- BBD $16,114,445,927.00
- BNTX $3,380,387,551.00
- Revenue This Year
- BBD $72.65
- BNTX N/A
- Revenue Next Year
- BBD $8.90
- BNTX $13.50
- P/E Ratio
- BBD $8.13
- BNTX N/A
- Revenue Growth
- BBD 27.09
- BNTX 6.98
- 52 Week Low
- BBD $1.84
- BNTX $81.20
- 52 Week High
- BBD $3.24
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- BBD 63.96
- BNTX 42.26
- Support Level
- BBD $3.11
- BNTX $90.12
- Resistance Level
- BBD $3.22
- BNTX $104.48
- Average True Range (ATR)
- BBD 0.07
- BNTX 3.98
- MACD
- BBD 0.01
- BNTX -0.47
- Stochastic Oscillator
- BBD 82.76
- BNTX 37.93
About BBD Banco Bradesco Sa
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation—a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.